An experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read More
Alzheimer's Disease
Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer’s
(By Andrew Joseph for STAT) When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read MoreLeqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read MoreStatement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read MoreWhy the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MoreAfter ICU discharge, Alzheimer’s patients’ risk of dying doubles: Study
(By Bari Faye Dean for Becker’s Hospital Review) Older adults with Alzheimer’s disease and related dementia are twice as likely
Read MoreAn Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreA loved one’s dementia will break your heart. Don’t let it wreck your finances
(By Sarah Boden for NPR) Sharon Gwinn had been married almost 30 years when she cleared out the savings and
Read MoreBy boosting memory consolidation, scientists may be able to help Alzheimer’s patients
(By Jon Hamilton for NPR) During sleep, the brain strengthens memories it expects to use in the future. Now, scientists
Read More